InQuest Science’s Chief Executive Officer and founder, Anthony Amato, is the newest member to join BioSig Technology’s Advisory Board. BioSig Technology is working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System. In 2017 Anthony founded InQuest Science, which focuses on troubleshooting product defect issues and providing training and guidance on particulate matter control, optimized inspection and 21CFR part 11 compliant electronic particulate and physical container/closure defect tracking systems. Bringing over twenty years of corporate executive leadership and entrepreneurial expertise in the medical industry. Mr. Amato has hands-on executive skills to grow business and optimize profits. Together, this team brings a distinctive skill set to managing and growing the company.
